The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
Clinical trial NCT07362355 · RECRUITING
Trial details
- NCT number
- NCT07362355
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-09
- Primary completion
- 2027-07-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.